The technology sector continued to dominate VC investments in 2013, accounting for 55% of the total investments. Within technology, sub-sectors like software, mobile, and e-commerce attracted significant attention from investors.
A workshop held in Granada in September 2013 aimed to bridge the gap between low-grade inflammation and diet-related chronic conditions like Type 2 Diabetes Mellitus (T2DM) and Cardiovascular Disease (CVD), emphasizing inflammation as a "friend and foe" in immunity. vc 2013
The year 2013 was a pivotal moment in medical research, particularly in the fields of cancer care, nutritional science, and public health policy, often referenced as "VC 2013" in longitudinal studies and retrospective analyses. During this time, significant research was published in high-impact journals, focusing on enhancing survivorship care, understanding the biological bases of disease, and implementing novel treatments. Advances in Cancer Survivorship and Care The technology sector continued to dominate VC investments
A major focus in 2013 was improving the quality of life and long-term outcomes for the growing population of cancer survivors, which was estimated to reach nearly 18 million by 2022. The year 2013 was a pivotal moment in
One of the notable trends in 2013 was the emergence of mega-deals, which are investments exceeding $100 million. The report highlights that mega-deals accounted for 10% of the total VC investments in 2013, up from 7% in 2012. These large investments were primarily focused on companies in the technology, healthcare, and clean technology sectors.
In 2026, MSVC 2022 (v143) offers full C++20, most of C++23, better security mitigations, and faster build times. However, if you must maintain a product that only builds under VC 2013, consider containerizing the build with a Windows Server 2012 R2 Docker image or using a VM snapshot.